Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that occurs ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Popular injectable weight loss drug Zepbound has become the first prescription drug that can be taken to treat obstructive sleep apnea. It has been approved by the FDA specifically for people who are ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

A very common medical condition globally, sleep apnea is a disorder that interrupts breathing during sleep. Several factors can cause it, though the risk rises sharply with obesity because extra fat ...